Beijing Junlikang Biotechnology

Beijing Junlikang Biotechnology is a specialized biotechnology firm based in Beijing, China, dedicated to the development and commercialization of micro-ecological biological products. Established in 2002, the company has become a leader in the research of Clostridium butyricum, a beneficial bacterium used to restore intestinal health. Its flagship product, marketed under the brand name Junlikang, is a pharmaceutical-grade probiotic preparation indicated for the treatment of acute and chronic diarrhea, enteritis, and various forms of intestinal dysbiosis. The company operates advanced GMP-certified production lines for live bacterial preparations, ensuring high standards of stability and efficacy. By focusing on the human microbiome, Beijing Junlikang Biotechnology aims to provide effective therapeutic solutions for gastrointestinal and immune-related conditions.